69 related articles for article (PubMed ID: 20570289)
1. Early stroke treatment with IV t-PA associated with early recanalization.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Matsumoto N; Yamashita S
J Neurol Sci; 2010 Aug; 295(1-2):53-7. PubMed ID: 20570289
[TBL] [Abstract][Full Text] [Related]
2. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tissue plasminogen activator thrombolysis in patients without major arterial occlusion seems to be safe and effective.
Kimura K; Iguchi Y; Shibazaki K; Sakamoto Y; Watanabe M
Eur Neurol; 2010; 64(5):258-64. PubMed ID: 20948218
[TBL] [Abstract][Full Text] [Related]
5. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
8. Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke?
Kimura K; Sakai K; Iguchi Y; Shibazaki K; Sakamoto Y
Eur Neurol; 2011; 65(5):245-9. PubMed ID: 21464569
[TBL] [Abstract][Full Text] [Related]
9. IV t-PA therapy in acute stroke patients with atrial fibrillation.
Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Yamashita S; Aoki J
J Neurol Sci; 2009 Jan; 276(1-2):6-8. PubMed ID: 19010485
[TBL] [Abstract][Full Text] [Related]
10. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
12. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
14. Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion.
Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Aoki J
J Neurol Sci; 2009 Oct; 285(1-2):130-3. PubMed ID: 19573877
[TBL] [Abstract][Full Text] [Related]
15. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV;
Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
19. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
20. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
